Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 52Plasma cell 43Other hematologic neoplasm 35Myeloid 12Sarcoma 6CNS 5Gastrointestinal 3Dermatologic 2Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Pancreatic Neoplasms 1Ovarian Neoplasms 1Colorectal Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
plerixafor × Gynecologic × Clear all
NCT02179970 2019-07-23

CAM-PLEX

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Completed
26 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡